Edwards Lifesciences Corp (NYSE:EW)

CAPS Rating: 3 out of 5

A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.

Recs

0
Player Avatar ll0o0ll (99.36) Submitted: 5/21/2007 10:49:14 AM : Outperform Start Price: $24.84 EW Score: +260.37

Terrific company ttat pursue a technology to allow cardio vault placement without major surgery.

Featured Broker Partners


Advertisement